Par C209 (Fenofibric acid delayed-release 45 mg)
Pill imprint Par C209 has been identified as Fenofibric acid delayed-release 45 mg.
Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 45 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about fenofibric acid
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.